title: Captopril test can give misleading results in patients with suspect primary aldosteronism.
authors.forename: Paolo
authors.initials: P
authors.lastname: Mulatero
authors.forename: Chiara
authors.initials: C
authors.lastname: Bertello
authors.forename: Corrado
authors.initials: C
authors.lastname: Garrone
authors.forename: Denis
authors.initials: D
authors.lastname: Rossato
authors.forename: Giulio
authors.initials: G
authors.lastname: Mengozzi
authors.forename: Andrea
authors.initials: A
authors.lastname: Verhovez
authors.forename: Francesco
authors.initials: F
authors.lastname: Fallo
authors.forename: Franco
authors.initials: F
authors.lastname: Veglio
mesh_terms: D000450:Aldosterone / Q000097:blood; D002216:Captopril; D019411:Clinical Laboratory Techniques; D015331:Cohort Studies; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis*; D006973:Hypertension / Q000097:blood / Q000175:diagnosis*; D008297:Male; D012084:Renin-Angiotensin System; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012965:Sodium Chloride
chemical_list: D012965:Sodium Chloride; D000450:Aldosterone; D002216:Captopril